Clinical Trial

Impact of Ehlers-Danlos Syndrome on Gynaecological Health

Study acronym: GYNESED
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 10, 2026 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Dysmenorrhea is a common problem in gynaecology, significantly impacting patients' quality of life. Ehlers-Danlos syndrome (EDS) is associated with joint hypermobility, tissue fragility and chronic pain. Some studies suggest an increased prevalence of gynaecological disorders, including dysmenorrhea, in patients with EDS. However, data remain limited and few studies have compared the intensity and characteristics of dysmenorrhea in women with EDS. There is also little data on the prevalence of other gynaecological conditions in women with EDS. This study therefore aims to compare the severity of dysmenorrhea in patients with EDS and a control group in order to better characterise the gynaecological impact of EDS. It will also compare the prevalence of other gynaecological conditions between women with EDS and women without EDS.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-28.
Status change: Not Yet Recruiting → Recruiting 2026-06-08
Trial Details
NCT Number NCT07151274
Lead Sponsor University Hospital, Rouen
Conditions Ehlers-Danlos Syndrome (EDS)
Enrollment 156 participants
Start Date 2025-07-07
Primary Completion 2026-07-01 (estimated)
Study Completion 2026-08-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-10